Interactieve versie
U vindt veel meer informatie per bedrijf en veel meer bedrijven. Ook kunt u filters toepassen en exporteren naar Excel.
Amylyx Pharmaceuticals EMEA B.V.
Amsterdam - Noord-Holland
www.amylyx.com
Naam
Amylyx Pharmaceuticals EMEA B.V.
Sector
Natuurwetenschappelijk onderzoek en experimentele ontwikkeling
Werkenden
5-9 wn.
Adres
Adres verborgen. Dit bedrijf wil geen ongevraagde postreclame of verkoop aan de deur.
Postcode
1083HN
Plaatsnaam
Amsterdam
000 06 08 090 14 15 19 20 2026 23 24th 3 30 35.50 500 9 a about accomplish action addition advanc agnostic all alongsid am amlx amylyx amyotrophic an and announced announces annual approaches are as assembled at audacious august avexitid bariatric based be becaus behalf betwen biomarker breaking c can cardiometabolic carer caring carry center challenges chart chat clear clinical cod commitment common communities community company complianc condition conduct conferenc connection consumer contact cookie corporat counting created critical cultur dat data decision defined deliver develop diseases driv each efficacy email era experienc experienced explor families featur find firesid for forum foundation from global greatest guidelines has hav health healthcar her high highlight history hom hypoglycemia impact inc individual insight integrity investigational investor it its join just know lat late-break lateral latest learn legacies list living loved lucidity mak management matched mechanistic media medicin million mission modality mor morgan nasdaq ned new next not notic novel now obstacles october offer on ones open opportunities or oral organization other our out outcomes path pbh peopl per personal perspectiv pharmaceutical phas pipelin plac position possibl post post-bariatric preclinical present presentation pric pricing privacy promis public purchas question rational read ready reserved responsibility right rigor rigorous rooted s safety scienc sclerosis see september serious serv services ses set shar shares social solution som sped stanley stay stifel stock subscrib supplier support syndrom system tailored tak talented team term territories th than that the their therapeutic therapies they to today toplin toughest treating trial tuesday two underwrit unmet up upcom updates upsized urgency us use usher ve virtual we wednesday well well-defined what wher which will window with within without wolfram work working would
Vind meer informatie over Amylyx Pharmaceuticals EMEA B.V. in de interactieve versie